Janney Montgomery Scott’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46.7M Buy
770,244
+49,310
+7% +$2.87M 0.12% 179
2025
Q4
$38.9M Buy
720,934
+72,244
+11% +$3.48M 0.09% 223
2025
Q3
$29.3M Sell
648,690
-57,171
-8% -$2.67M 0.07% 271
2025
Q2
$32.7M Sell
705,861
-273,099
-28% -$13.4M 0.09% 232
2025
Q1
$59.7M Buy
978,960
+24,233
+3% +$1.41M 0.17% 129
2024
Q4
$54M Buy
954,727
+217,603
+30% +$12.2M 0.15% 139
2024
Q3
$38.1M Buy
737,124
+22,508
+3% +$1.06M 0.11% 192
2024
Q2
$29.7M Sell
714,616
-224,462
-24% -$10M 0.09% 220
2024
Q1
$50.9M Buy
939,078
+87,690
+10% +$4.47M 0.15% 135
2023
Q4
$43.7M Buy
851,388
+96,733
+13% +$5.08M 0.14% 146
2023
Q3
$43.8M Sell
754,655
-8,962
-1% -$549K 0.16% 121
2023
Q2
$48.8M Buy
763,617
+7,382
+1% +$495K 0.17% 120
2023
Q1
$52.4M Buy
756,235
+16,564
+2% +$1.17M 0.21% 103
2022
Q4
$53.2M Sell
739,671
-14,829
-2% -$1.12M 0.21% 109
2022
Q3
$53.6M Sell
754,500
-1,046
-0.1% -$75.9K 0.23% 94
2022
Q2
$59.3M Sell
755,546
-95,994
-11% -$7.31M 0.27% 83
2022
Q1
$62.2M Buy
851,540
+18,391
+2% +$1.23M 0.27% 84
2021
Q4
$51.9M Sell
833,149
-9,720
-1% -$570K 0.2% 112
2021
Q3
$49.9M Sell
842,869
-70
-0% -$4.61K 0.21% 108
2021
Q2
$56.3M Sell
842,939
-32,287
-4% -$2.11M 0.25% 93
2021
Q1
$55.3M Buy
875,226
+13,835
+2% +$861K 0.27% 89
2020
Q4
$53.4M Buy
861,391
+30,950
+4% +$1.9M 0.26% 92
2020
Q3
$50.1M Buy
830,441
+26,942
+3% +$1.62M 0.29% 85
2020
Q2
$47.2M Buy
803,499
+37,320
+5% +$2.23M 0.3% 78
2020
Q1
$42.7M Buy
766,179
+2,846
+0.4% +$174K 0.34% 71
2019
Q4
$49M Buy
763,333
+52,200
+7% +$2.99M 0.32% 73
2019
Q3
$36.1M Buy
711,133
+77,690
+12% +$3.65M 0.26% 91
2019
Q2
$28.7M Sell
633,443
-83,495
-12% -$3.89M 0.22% 104
2019
Q1
$34.2M Buy
716,938
+138,363
+24% +$6.89M 0.28% 87
2018
Q4
$30.1M Sell
578,575
-2,095
-0.4% -$113K 0.29% 84
2018
Q3
$36M Sell
580,670
-10,048
-2% -$596K 0.31% 77
2018
Q2
$32.7M Sell
590,718
-5,336
-0.9% -$288K 0.31% 75
2018
Q1
$37.7M Sell
596,054
-7,085
-1% -$456K 0.38% 66
2017
Q4
$37M Sell
603,139
-15,438
-2% -$966K 0.38% 65
2017
Q3
$39.4M Buy
618,577
+13,120
+2% +$766K 0.45% 48
2017
Q2
$33.7M Buy
605,457
+28,395
+5% +$1.55M 0.42% 57
2017
Q1
$31.4M Sell
577,062
-29,734
-5% -$1.63M 0.42% 55
2016
Q4
$35.5M Buy
606,796
+12,190
+2% +$666K 0.53% 37
2016
Q3
$32.1M Sell
594,606
-493,008
-45% -$31.7M 0.56% 36
2016
Q2
$80M Buy
1,087,614
+633,130
+139% +$44.7M 1.63% 11
2016
Q1
$29M Buy
454,484
+42,014
+10% +$2.65M 0.76% 24
2015
Q4
$28.4M Sell
412,470
-3,702
-0.9% -$245K 0.73% 22
2015
Q3
$24.6M Buy
416,172
+29,633
+8% +$1.88M 0.7% 24
2015
Q2
$25.7M Buy
386,539
+21,935
+6% +$1.45M 0.54% 28
2015
Q1
$23.5M Buy
364,604
+4,695
+1% +$294K 0.44% 25
2014
Q4
$21.2M Buy
359,909
+8,876
+3% +$501K 0.43% 29
2014
Q3
$18M Buy
351,033
+12,753
+4% +$637K 0.37% 33
2014
Q2
$16.4M Buy
338,280
+4,827
+1% +$238K 0.36% 35
2014
Q1
$17.3M Buy
333,453
+37,114
+13% +$1.97M 0.42% 31
2013
Q4
$15.8M Buy
296,339
+10,144
+4% +$517K 0.42% 32
2013
Q3
$13.2M Buy
286,195
+162,445
+131% +$7.13M 0.4% 35
2013
Q2
$5.53M Buy
+123,750
New +$5.37M 0.58% 34

Other funds holding BMY

Janney Montgomery Scott's BMY Position: Q1 2026 in Review

Janney Montgomery Scott increased its Bristol-Myers Squibb (BMY) stake by 6.8% in Q1 2026, buying an estimated $2.87M and bringing the position to 770,244 shares worth $46.7M. The position accounts for 0.12% of the portfolio, ranked #179.

Janney Montgomery Scott first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $80M in Q2 2016. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Janney Montgomery Scott held 770,244 shares of Bristol-Myers Squibb worth $46.7M as of Q1 2026.
  • Janney Montgomery Scott bought 49,310 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.87M.
  • Bristol-Myers Squibb made up 0.12% of Janney Montgomery Scott's portfolio in Q1 2026, its #179 holding.
  • Janney Montgomery Scott first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Janney Montgomery Scott's Bristol-Myers Squibb position peaked at $80M in Q2 2016.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.